AVXL / Anavex Life Sciences Corp. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Anavex Life Sciences Corp.
US ˙ NasdaqGS ˙ US0327973006

Deler fremragende 92,671,758 shares
Insideraktier3.027.737 shares
Insider ejerskab3,27 %
Total Insiders11
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

0 ( )
5226 out of 10986

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

0.000% ( )
5326 out of 10856

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

Anavex Life Sciences Corp. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Sandra Boenisch PFO and Treasurer - [O] 22.963 22.963
Donhauser Peter D.O. Director - [D] 5.000 5.000
Elliot Favus Director - [D] 0 0
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Harvey Lalach President COO Secretary, Director - [D] [O] 550.000 137.500
Bernd Metzner 100.000
Christopher U Missling President and CEO, Director - [D] [O] 1.510.165 1.510.165
Jiong Ma 25.000
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Athanasios Skarpelos Director - [D] 1.306.458 1.306.458
George F Tidmarsh Executive Director, Director - [D] [O] 8.000 2.000
Steffen Thomas Director - [D] 43.651 43.651
Claus Vander Velden 25.000

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i AVXL / Anavex Life Sciences Corp.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2024-06-14 Donhauser Peter D.O. 2.835 3,6400 2.835 3,6400 10.319 207 13.4600 27.840 269,79
2024-05-15 Thomas Steffen 5.000 4,5200 5.000 4,5200 22.600
2021-05-17 Donhauser Peter D.O. 1.000 10,9300 1.000 10,9300 10.930
2021-02-19 Donhauser Peter D.O. 1.000 12,6200 1.000 12,6200 12.620
2021-02-19 Donhauser Peter D.O. 165 12,9700 165 12,9700 2.140

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

AVXL / Anavex Life Sciences Corp. Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i AVXL / Anavex Life Sciences Corp.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2024-03-28 MISSLING CHRISTOPHER U 73.380 5,1100 73.380 5,1100 374.972 28 3.3900 -126.213 -33,66
2023-06-28 MISSLING CHRISTOPHER U 268.000 7,9825 268.000 7,9825 2.139.310
2022-05-25 Skarpelos Athanasios 50.000 9,0600 50.000 9,0600 453.000
2021-06-29 MISSLING CHRISTOPHER U 51.620 26,0000 51.620 26,0000 1.342.120
2021-06-29 Boenisch Sandra 166.696 26,5300 166.696 26,5300 4.422.445
2021-05-21 FAVUS ELLIOT 145.000 11,6985 145.000 11,6985 1.696.282
2021-02-24 FAVUS ELLIOT 145.500 12,6588 145.500 12,6588 1.841.855
2012-05-29 Lalach Harvey 8.572 1,0500 2.143 4,2000 9.001
2012-05-24 Lalach Harvey 10.000 0,8000 2.500 3,2000 8.000

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

AVXL / Anavex Life Sciences Corp. Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2025-09-12 2025-09-11 4 MISSLING CHRISTOPHER U AVXL Common Stock F - Taxes D 9,5800 -145.048 -1.390 1.510.165
2025-09-12 2025-09-11 4 MISSLING CHRISTOPHER U AVXL Common Stock M - Exercise D 5,0400 187.500 945 1.655.213
2025-06-09 2025-06-05 4 Thomas Steffen AVXL Common stock F - Taxes D 7,7500 -11.349 -88 43.651
2025-06-09 2025-06-05 4 Thomas Steffen AVXL Common stock M - Exercise D 1,7600 50.000 88 55.000
2025-03-26 2025-03-24 4 MISSLING CHRISTOPHER U AVXL Common Stock F - Taxes D 9,6300 -282.497 -2.720 1.467.713
2025-03-26 2025-03-24 4 MISSLING CHRISTOPHER U AVXL Common Stock M - Exercise D 0,9200 500.000 460 1.750.210
2024-06-17 2024-06-14 4 Donhauser Peter D.O. AVXL Common Stock P - Purchase D 3,6400 2.835 10 5.000
2024-05-17 2024-05-15 4 Thomas Steffen AVXL Common Stock P - Purchase D 4,5200 5.000 23 5.000
2024-04-01 2024-03-28 4 MISSLING CHRISTOPHER U AVXL Common Stock S - Sale D 5,1100 -73.380 -375 1.250.210
2024-04-01 2024-03-28 4 MISSLING CHRISTOPHER U AVXL Common Stock M - Exercise D 1,3200 73.380 97 1.323.590
2023-06-30 2023-06-29 4 MISSLING CHRISTOPHER U AVXL Common Stock M - Exercise D 1,6000 232.000 371 1.250.210
2023-06-30 2023-06-28 4 MISSLING CHRISTOPHER U AVXL Common Stock S - Sale D 7,9825 -268.000 -2.139 1.018.210
2023-06-30 2023-06-28 4 MISSLING CHRISTOPHER U AVXL Common Stock M - Exercise D 1,6000 268.000 429 1.286.210
2022-05-27 2022-05-25 4 Skarpelos Athanasios AVXL Stock Option (Right to Buy) M - Exercise D 0,92 50.000 0
2022-05-27 2022-05-25 4 Skarpelos Athanasios AVXL Common Stock S - Sale D 9,0600 -50.000 -453 1.306.458
2022-05-27 2022-05-25 4 Skarpelos Athanasios AVXL Common Stock M - Exercise D 0,9200 50.000 46 1.356.458
2021-08-04 2021-08-02 4 Ma Jiong AVXL Stock Option (Right to Buy) A - Award D 18,11 25.000 25.000
2021-08-04 2021-08-02 4 Velden Claus Vander AVXL Stock Option (Right to Buy) A - Award D 18,11 25.000 25.000
2021-08-04 2021-08-02 4 Boenisch Sandra AVXL Stock Option (Right to Buy) A - Award D 18,11 40.000 40.000
2021-08-04 2021-08-02 4 Donhauser Peter D.O. AVXL Stock Option (Right to Buy) A - Award D 18,11 25.000 25.000
2021-08-04 2021-08-02 4 Thomas Steffen AVXL Stock Option (Right to Buy) A - Award D 18,11 25.000 25.000
2021-08-04 2021-08-02 4 Skarpelos Athanasios AVXL Stock Option (Right to Buy) A - Award D 18,11 25.000 25.000
2021-08-04 2021-08-02 4 MISSLING CHRISTOPHER U AVXL Stock Option (Right to Buy) A - Award D 18,11 500.000 500.000
2021-07-01 2021-06-29 4 MISSLING CHRISTOPHER U AVXL Stock Option (Right to Buy) M - Exercise D 1,32 -51.620 73.380
2021-07-01 2021-06-29 4 MISSLING CHRISTOPHER U AVXL Common Stock S - Sale D 26,0000 -51.620 -1.342 1.018.210
2021-07-01 2021-06-29 4 MISSLING CHRISTOPHER U AVXL Common Stock M - Exercise D 1,3200 51.620 68 1.069.830
2021-07-01 2021-06-29 4 Boenisch Sandra AVXL Stock Option (Right to Buy) M - Exercise D 5,92 -35.000 0
2021-07-01 2021-06-29 4 Boenisch Sandra AVXL Stock Option (Right to Buy) M - Exercise D 3,28 -106.696 0
2021-07-01 2021-06-29 4 Boenisch Sandra AVXL Stock Option (Right to Buy) M - Exercise D 5,68 -25.000 0
2021-07-01 2021-06-29 4 Boenisch Sandra AVXL Common Stock S - Sale D 26,5300 -166.696 -4.422 22.963
2021-07-01 2021-06-29 4 Boenisch Sandra AVXL Common Stock M - Exercise D 5,9200 35.000 207 189.659
2021-07-01 2021-06-29 4 Boenisch Sandra AVXL Common Stock M - Exercise D 3,2800 106.696 350 154.659
2021-07-01 2021-06-29 4 Boenisch Sandra AVXL Common Stock M - Exercise D 5,6800 25.000 142 47.963
2021-05-25 2021-05-21 4 FAVUS ELLIOT AVXL Stock Option (Right to Buy) M - Exercise D 2,96 -50.000 0
2021-05-25 2021-05-21 4 FAVUS ELLIOT AVXL Stock Option (Right to Buy) M - Exercise D 0,92 -50.000 0
2021-05-25 2021-05-21 4 FAVUS ELLIOT AVXL Stock Option (Right to Buy) M - Exercise D 6,11 -1.500 0
2021-05-25 2021-05-21 4 FAVUS ELLIOT AVXL Stock Option (Right to Buy) M - Exercise D 5,64 -1.500 0
2021-05-25 2021-05-21 4 FAVUS ELLIOT AVXL Stock Option (Right to Buy) M - Exercise D 5,66 -1.500 0
2021-05-25 2021-05-21 4 FAVUS ELLIOT AVXL Stock Option (Right to Buy) M - Exercise D 4,90 -1.500 0
2021-05-25 2021-05-21 4 FAVUS ELLIOT AVXL Stock Option (Right to Buy) M - Exercise D 5,57 -1.500 0
2021-05-25 2021-05-21 4 FAVUS ELLIOT AVXL Stock Option (Right to Buy) M - Exercise D 1,20 -37.500 0
2021-05-25 2021-05-21 4 FAVUS ELLIOT AVXL Common Stock S - Sale D 11,6985 -145.000 -1.696 0
2021-05-25 2021-05-21 4 FAVUS ELLIOT AVXL Common Stock M - Exercise D 2,9600 50.000 148 145.000
2021-05-25 2021-05-21 4 FAVUS ELLIOT AVXL Common Stock M - Exercise D 6,1100 1.500 9 95.000
2021-05-25 2021-05-21 4 FAVUS ELLIOT AVXL Common Stock M - Exercise D 5,6600 1.500 8 93.500
2021-05-25 2021-05-21 4 FAVUS ELLIOT AVXL Common Stock M - Exercise D 4,9000 1.500 7 92.000
2021-05-25 2021-05-21 4 FAVUS ELLIOT AVXL Common Stock M - Exercise D 5,5700 1.500 8 90.500
2021-05-25 2021-05-21 4 FAVUS ELLIOT AVXL Common Stock M - Exercise D 5,6400 1.500 8 89.000
2021-05-25 2021-05-21 4 FAVUS ELLIOT AVXL Common Stock M - Exercise D 0,9200 50.000 46 87.500
2021-05-25 2021-05-21 4 FAVUS ELLIOT AVXL Common Stock M - Exercise D 1,2000 37.500 45 37.500
2021-05-19 2021-05-17 4 Donhauser Peter D.O. AVXL Common Stock P - Purchase D 10,9300 1.000 11 2.165
2021-02-26 2021-02-24 4 FAVUS ELLIOT AVXL Stock Option (Right to Buy) M - Exercise D 3,28 -100.000 0
2021-02-26 2021-02-24 4 FAVUS ELLIOT AVXL Stock Option (Right to Buy) M - Exercise D 2,58 -45.500 0
2021-02-26 2021-02-24 4 FAVUS ELLIOT AVXL Common Stock S - Sale D 12,6588 -145.500 -1.842 0
2021-02-26 2021-02-24 4 FAVUS ELLIOT AVXL Common Stock M - Exercise D 3,2800 100.000 328 145.000
2021-02-26 2021-02-24 4 FAVUS ELLIOT AVXL Common Stock M - Exercise D 2,5800 45.500 117 45.000
2021-02-23 2021-02-19 4 Donhauser Peter D.O. AVXL Common Stock P - Purchase D 12,9700 165 2 1.165
2021-02-23 2021-02-19 4 Donhauser Peter D.O. AVXL Common Stock P - Purchase D 12,6200 1.000 13 1.000
2021-01-04 2020-12-30 4 Skarpelos Athanasios AVXL Stock Option (Right to Buy) A - Award D 5,49 35.000 35.000
2021-01-04 2020-12-30 4 Thomas Steffen AVXL Stock Option (Right to Buy) A - Award D 5,49 35.000 35.000
2021-01-04 2020-12-30 4 Boenisch Sandra AVXL Stock Option (Right to Buy) A - Award D 5,49 50.000 50.000
2021-01-04 2020-12-30 4 Donhauser Peter D.O. AVXL Stock Option (Right to Buy) A - Award D 5,49 35.000 35.000
2021-01-04 2020-12-30 4 FAVUS ELLIOT AVXL Stock Option (Right to Buy) A - Award D 5,49 35.000 35.000
2021-01-04 2020-12-30 4 Velden Claus Vander AVXL Stock Option (Right to Buy) A - Award D 5,49 35.000 35.000
2021-01-04 2020-12-30 4 MISSLING CHRISTOPHER U AVXL Stock Option (Right to Buy) A - Award D 5,49 550.000 550.000
2020-01-08 2020-01-06 4 Skarpelos Athanasios AVXL Stock Option (Right to Buy) A - Award D 2,96 50.000 50.000
2020-01-08 2020-01-06 4 Donhauser Peter D.O. AVXL Stock Option (Right to Buy) A - Award D 2,96 50.000 50.000
2020-01-08 2020-01-06 4 FAVUS ELLIOT AVXL Stock Option (Right to Buy) A - Award D 2,96 50.000 50.000
2020-01-08 2020-01-06 4 MISSLING CHRISTOPHER U AVXL Stock Option (Right to Buy) A - Award D 2,96 550.000 550.000
2020-01-08 2020-01-06 4 Thomas Steffen AVXL Stock Option (Right to Buy) A - Award D 2,96 50.000 50.000
2020-01-08 2020-01-06 4 Velden Claus Vander AVXL Stock Option (Right to Buy) A - Award D 2,96 50.000 50.000
2020-01-08 2020-01-06 4 Boenisch Sandra AVXL Stock Option (Right to Buy) A - Award D 2,96 70.000 70.000
2019-06-06 2019-06-04 4 Boenisch Sandra AVXL Stock Option (Right to Buy) A - Award D 2,93 35.000 35.000
2019-05-07 2019-05-03 4 MISSLING CHRISTOPHER U AVXL Stock Option (Right to Buy) A - Award D 3,15 750.000 750.000
2018-10-09 2018-10-01 4 Skarpelos Athanasios AVXL Stock Option (Right to Buy) A - Award D 2,58 45.500 45.500
2018-10-03 2018-10-01 4 Donhauser Peter D.O. AVXL Stock Option (Right to Buy) A - Award D 2,58 45.500 45.500
2018-10-03 2018-10-01 4 Boenisch Sandra AVXL Stock Option (Right to Buy) A - Award D 2,58 27.300 27.300
2018-10-03 2018-10-01 4 Thomas Steffen AVXL Stock Option (Right to Buy) A - Award D 2,58 45.500 45.500
2018-10-03 2018-10-01 4 MISSLING CHRISTOPHER U AVXL Stock Option (Right to Buy) A - Award D 2,58 409.500 409.500
2018-10-03 2018-10-01 4 Velden Claus Vander AVXL Stock Option (Right to Buy) A - Award D 2,58 45.500 45.500
2018-10-03 2018-10-01 4 FAVUS ELLIOT AVXL Stock Option (Right to Buy) A - Award D 2,58 45.500 45.500
2018-05-17 2018-05-15 4 Boenisch Sandra AVXL Stock Option (Right to Buy) A - Award D 2,30 30.000 30.000
2018-05-17 2018-05-15 4 MISSLING CHRISTOPHER U AVXL Stock Option (Right to Buy) A - Award D 2,30 450.000 450.000
2018-03-09 2018-03-07 4 MISSLING CHRISTOPHER U AVXL Common Stock P - Purchase D 2,9200 1.360 4 1.018.210
2018-03-07 2018-03-06 4 MISSLING CHRISTOPHER U AVXL Common Stock P - Purchase D 2,7300 1.450 4 1.016.850
2018-03-06 2018-03-05 4 MISSLING CHRISTOPHER U AVXL Common Stock P - Purchase D 2,6300 1.500 4 1.015.400
2018-03-05 2018-03-02 4 MISSLING CHRISTOPHER U AVXL Common Stock P - Purchase D 2,4100 1.650 4 1.013.900
2017-12-15 2017-12-13 4 MISSLING CHRISTOPHER U AVXL Stock Option (Right to Buy) A - Award D 3,30 400.000 400.000
2017-12-15 2017-12-13 4 Boenisch Sandra AVXL Stock Option (Right to Buy) A - Award D 3,30 30.000 30.000
2017-10-26 2017-10-25 4 MISSLING CHRISTOPHER U AVXL Common Stock P - Purchase D 4,3900 375 2 1.012.250
2017-10-24 2017-10-24 4 MISSLING CHRISTOPHER U AVXL Common Stock P - Purchase D 4,9200 375 2 1.011.875
2017-10-19 2017-10-19 4 MISSLING CHRISTOPHER U AVXL Common Stock P - Purchase D 4,4900 375 2 1.011.500
2017-10-18 2017-10-17 4 MISSLING CHRISTOPHER U AVXL Common Stock P - Purchase D 4,2700 375 2 1.011.125
2017-10-16 2017-10-13 4 MISSLING CHRISTOPHER U AVXL Common Stock P - Purchase D 4,2200 750 3 1.010.750
2017-10-05 2017-10-05 4 MISSLING CHRISTOPHER U AVXL Common Stock P - Purchase D 4,3000 375 2 1.010.000
2017-10-02 2017-10-02 4 MISSLING CHRISTOPHER U AVXL Common Stock P - Purchase D 4,2000 375 2 1.009.625
2017-09-29 2017-09-28 4 MISSLING CHRISTOPHER U AVXL Common Stock P - Purchase D 4,2100 375 2 1.009.250
2017-09-26 2017-09-26 4 MISSLING CHRISTOPHER U AVXL Common Stock P - Purchase D 3,8800 375 1 1.008.875
2017-09-20 2017-09-20 4 MISSLING CHRISTOPHER U AVXL Common Stock P - Purchase D 4,2300 375 2 1.008.500
2017-09-19 2017-09-18 4 MISSLING CHRISTOPHER U AVXL Common Stock P - Purchase D 4,4000 375 2 1.008.125
2017-09-14 2017-09-14 4 MISSLING CHRISTOPHER U AVXL Common Stock P - Purchase D 4,5800 375 2 1.007.750
2017-09-11 2017-09-11 4 MISSLING CHRISTOPHER U AVXL Common Stock P - Purchase D 4,8100 375 2 1.007.375
2017-09-08 2017-09-07 4 MISSLING CHRISTOPHER U AVXL Common Stock P - Purchase D 4,7600 375 2 1.007.000
2017-09-05 2017-09-05 4 MISSLING CHRISTOPHER U AVXL Common Stock P - Purchase D 4,9000 375 2 1.006.625
2017-08-31 2017-08-31 4 MISSLING CHRISTOPHER U AVXL Common Stock P - Purchase D 4,4800 375 2 1.006.250
2017-08-29 2017-08-28 4 MISSLING CHRISTOPHER U AVXL Common Stock P - Purchase D 4,4400 375 2 1.005.875
2017-08-25 2017-08-24 4 MISSLING CHRISTOPHER U AVXL Common Stock P - Purchase D 4,5400 375 2 1.005.500
2017-08-21 2017-08-21 4 MISSLING CHRISTOPHER U AVXL Common Stock P - Purchase D 4,0700 375 2 1.005.125
2017-08-18 2017-08-18 4 MISSLING CHRISTOPHER U AVXL Common Stock P - Purchase D 3,8100 375 1 1.004.750
2017-08-14 2017-08-14 4 MISSLING CHRISTOPHER U AVXL Common Stock P - Purchase D 3,7000 375 1 1.004.375
2017-08-11 2017-08-11 4 MISSLING CHRISTOPHER U AVXL Common Stock P - Purchase D 3,5500 750 3 1.004.000
2017-05-15 2017-05-12 4 Boenisch Sandra AVXL Stock Option (Right to Buy) A - Award D 5,92 35.000 35.000
2017-05-15 2017-05-12 4 MISSLING CHRISTOPHER U AVXL Stock Option (Right to Buy) A - Award D 5,92 450.000 450.000
2016-09-26 2016-09-22 4 MISSLING CHRISTOPHER U AVXL Stock Option (Right to Buy) A - Award D 3,28 500.000 500.000
2016-09-26 2016-09-22 4 Skarpelos Athanasios AVXL Stock Option (Right to Buy) A - Award D 3,28 100.000 100.000
2016-09-26 2016-09-22 4 FAVUS ELLIOT AVXL Stock Option (Right to Buy) A - Award D 3,28 100.000 100.000
2016-09-26 2016-09-22 4 METZNER BERND AVXL Stock Option (Right to Buy) A - Award D 3,28 100.000 100.000
2016-09-26 2016-09-22 4 Thomas Steffen AVXL Stock Option (Right to Buy) A - Award D 3,28 100.000 100.000
2016-09-26 2016-09-22 4 Boenisch Sandra AVXL Stock Option (Right to Buy) A - Award D 3,28 106.696 106.696
2016-07-19 2016-07-18 4 MISSLING CHRISTOPHER U AVXL Stock Option (Right to Buy) A - Award D 7,06 861.429 861.429
2016-07-19 2016-07-05 4 MISSLING CHRISTOPHER U AVXL Stock Option (Right to Buy) A - Award D 6,26 379.625 379.625
2016-07-05 2016-06-30 4 FAVUS ELLIOT AVXL Stock Option (Right to Buy) A - Award D 6,11 1.500 1.500
2016-05-02 2015-12-31 4/A FAVUS ELLIOT AVXL Stock Option (Right to Buy) A - Award D 5,57 1.500 1.500
2016-05-02 2015-09-30 4/A FAVUS ELLIOT AVXL Stock Option (Right to Buy) A - Award D 5,64 1.500 1.500
2016-05-02 2016-04-27 4 FAVUS ELLIOT AVXL Stock Option (Right to Buy) A - Award D 5,66 1.500 1.500
2016-05-02 2016-03-31 4 FAVUS ELLIOT AVXL Stock Option (Right to Buy) A - Award D 4,90 1.500 1.500
2016-04-18 2015-04-02 4 Skarpelos Athanasios AVXL Stock Option (Right to Buy) A - Award D 0,92 50.000 50.000
2016-04-18 2015-04-02 4 METZNER BERND AVXL Stock Option (Right to Buy) A - Award D 0,92 50.000 87.500
2016-02-23 2015-12-31 4 FAVUS ELLIOT AVXL Stock Option/Right to Buy A - Award D 1,68 4.500 92.000
2016-02-23 2015-04-02 4 FAVUS ELLIOT AVXL Stock Option/Right to Buy A - Award D 0,92 50.000 87.500
2015-11-16 2015-09-18 5 MISSLING CHRISTOPHER U AVXL Stock option A - Award D 5,04 187.500 187.500
2015-11-16 2015-04-02 5 MISSLING CHRISTOPHER U AVXL Stock option A - Award D 0,92 500.000 500.000
2015-10-09 3 Boenisch Sandra AVXL Common stock D 163.700
2015-10-09 3 Boenisch Sandra By Estate of Roy James Rattenbury Testamentary Trust for Children of Sandra Boenisch AVXL Common stock I 111.850
2015-10-09 3 Boenisch Sandra AVXL Common stock D 163.700
2015-10-09 3 Boenisch Sandra By Estate of Roy James Rattenbury Testamentary Trust for Children of Sandra Boenisch AVXL Common stock I 111.850
2015-07-14 2015-07-14 4 MISSLING CHRISTOPHER U AVXL Common stock P - Purchase D 0,5184 1.000 1 4.013.000
2015-07-14 2015-07-13 4 MISSLING CHRISTOPHER U AVXL Common stock P - Purchase D 0,5295 1.000 1 4.012.000
2015-07-07 2015-07-07 4 MISSLING CHRISTOPHER U AVXL Common stock P - Purchase D 0,5099 1.000 1 4.011.000
2015-07-07 2015-07-06 4 MISSLING CHRISTOPHER U AVXL Common stock P - Purchase D 0,4695 1.000 0 4.010.000
2015-07-01 2015-07-01 4 MISSLING CHRISTOPHER U AVXL Common stock P - Purchase D 0,4548 1.000 0 3.009.000
2015-07-01 2015-06-30 4 MISSLING CHRISTOPHER U AVXL Common stock P - Purchase D 0,4446 1.000 0 3.008.000
2015-06-23 2015-06-23 4 MISSLING CHRISTOPHER U AVXL Common stock P - Purchase D 0,4680 1.000 0 3.007.000
2015-06-22 2015-06-22 4 MISSLING CHRISTOPHER U AVXL Common stock P - Purchase D 0,4150 1.000 0 3.006.000
2015-06-16 2015-06-16 4 MISSLING CHRISTOPHER U AVXL Common stock P - Purchase D 0,4420 1.000 0 3.005.000
2015-06-15 2015-06-15 4 MISSLING CHRISTOPHER U AVXL Common stock P - Purchase D 0,4280 1.000 0 3.004.000
2015-06-12 2015-06-10 4 MISSLING CHRISTOPHER U AVXL Common stock P - Purchase D 0,3550 1.000 0 3.003.000
2015-06-09 2015-06-08 4 MISSLING CHRISTOPHER U AVXL Common stock P - Purchase D 0,3520 1.000 0 3.002.000
2015-06-05 2015-06-04 4 MISSLING CHRISTOPHER U AVXL Common stock P - Purchase D 0,3685 1.000 0 3.001.000
2013-12-04 2013-11-28 4 Skarpelos Athanasios AVXL Common Stock G - Gift D -300.000 5.225.832
2013-11-05 2013-10-29 4 Skarpelos Athanasios AVXL Common Stock G - Gift D -200.000 5.525.832
2013-11-05 2013-10-01 4 Skarpelos Athanasios AVXL Common Stock G - Gift D -1.000.000 5.725.832
2013-07-15 3 MISSLING CHRISTOPHER U AVXL Common Stock D 4.000.000
2012-05-29 2012-05-29 4 Lalach Harvey AVXL common stock S - Sale D 1,0500 -8.572 -9 550.000
2012-05-29 2012-05-24 4 Lalach Harvey AVXL common stock S - Sale D 0,8000 -10.000 -8 558.572
2012-02-10 2012-02-09 4 TIDMARSH GEORGE F AVXL warrants J - Other D 2,00 4.000 4.000
2012-02-10 2012-02-09 4 TIDMARSH GEORGE F AVXL common stock J - Other D 1,2500 8.000 10 8.000
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
Other Listings
DE:12X1 2,66 €
GB:0HFR 3,30 $
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista